abstract |
The present disclosure relates to humanized monoclonal antibodies that are capable of inhibiting Fc [gamma] RIA binding molecules, such as Fc [gamma] RIA activity, and Fc [gamma] RIA binding in the treatment or prevention of, for example, inflammatory, Lt; RTI ID = 0.0 > molecular < / RTI > |